Fulgenzi Alessandro, Vietti Daniele, Ferrero Maria Elena
Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Via Luigi Mangiagall, 31, 20133 Milano, Italy.
Biomed Res Int. 2014;2014:758323. doi: 10.1155/2014/758323. Epub 2014 Aug 27.
The aetiology of neurodegenerative diseases (ND) seems to involve susceptibility genes and environmental factors. Toxic metals are considered major environmental pollutants. Following our study of a case of multiple sclerosis (MS) improvement due to removal of aluminium (Al) and other toxic metals, we have examined the possible relationship between Al intoxication and ND. We used the slow intravenous treatment with the chelating agent EDTA (calcium disodium ethylene diamine tetraacetic acid) (chelation test) to remove Al and detected it in the urine collected from the patients for 12 hours. Patients affected by MS represented 85.6% of total ND. Al was present in 44.8% of cases comprehensive of ND and healthy patients. Al levels were significantly higher in ND patients than in healthy subjects. We here show that treatment of patients affected by Al burden with ten EDTA chelation therapies (EDTA intravenous administration once a week) was able to significantly reduce Al intoxication.
神经退行性疾病(ND)的病因似乎涉及易感基因和环境因素。有毒金属被认为是主要的环境污染物。在我们对一例因去除铝(Al)和其他有毒金属而病情改善的多发性硬化症(MS)病例进行研究之后,我们研究了铝中毒与神经退行性疾病之间的可能关系。我们采用螯合剂乙二胺四乙酸二钠钙(EDTA)进行缓慢静脉治疗(螯合试验)以去除铝,并在患者12小时的尿液中进行检测。患有多发性硬化症的患者占神经退行性疾病患者总数的85.6%。在包括神经退行性疾病患者和健康患者的所有病例中,44.8%检测出铝。神经退行性疾病患者的铝含量显著高于健康受试者。我们在此表明,对铝负荷过高的患者进行十次EDTA螯合治疗(每周静脉注射一次EDTA)能够显著减轻铝中毒。